Leon O. Moulder, Jr. 13D and 13G filings for Zenas BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-06 4:10 pm Purchase | 2025-05-30 | 13D | Zenas BioPharma, Inc. ZBIO | Leon O. Moulder, Jr. | 2,098,646 5.000% | 2,098,646 (New Position) | Filing |